Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company advancing a pipeline of innovative inflammation and immunology therapeutics, and the owner of Scinai Biopharma Services...

Frazier/Fenwick Winter Investor Event, March 7-10 Oppenheimer 33rd Annual Healthcare Conference, March 13-15 – Corporate presentation will be held on Monday, March 13, at 4:00 p.m. ET BIO-Europe...

AGC Biologics is pleased to be a gold sponsor of BIO-Europe Spring, Europe's largest springtime biotech partnering event. In order to ensure the health of all those participating, the event will...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet...

Symic Bio, a biopharmaceutical company focused on matrix biology that is developing a new category of therapeutics, today announced that Rinko Ghosh, President and Chief Business Officer, will...